B7-H3 expression in upper tract urothelial carcinoma associates with adverse clinicopathological features and poor survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

B7-H3 expression in upper tract urothelial carcinoma associates with adverse clinicopathological features and poor survival

Published:2020-12 Issue:12 Volume:216 Page:153219
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Koyama Yuichi,Morikawa Teppei,Miyama Yu,Miyakawa Jimpei,Kawai Taketo,Kume Haruki,Sawabe Motoji,Ushiku Tetsuo

Funder

Japan Society for the Promotion of Science.

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference36 articles.

1. European guidelines on upper tract urothelial carcinomas: 2013 update;Roupret;Eur. Urol.,2013

2. Recent advances in upper tract urothelial carcinomas: from bench to clinics;Shao;Int. J. Urol.,2019

3. B7-H3 role in the immune landscape of cancer;Castellanos;Am. J. Clin. Exp. Immunol.,2017

4. B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer;Ingebrigtsen;Int. J. Cancer,2012

5. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma;Sun;Cancer Immunol. Immunother.,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives;Current Oncology Reports;2023-10-06

2. A CD276-Targeted Antibody-Drug Conjugate to Treat Non-Small Lung Cancer (NSCLC);Cells;2023-09-30

3. The Immune Landscape and Therapy of Upper Tract Urothelial Carcinoma;Interdisciplinary Cancer Research;2023

4. B7 family protein glycosylation: Promising novel targets in tumor treatment;Frontiers in Immunology;2022-12-06

5. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy;Journal of Hematology & Oncology;2022-10-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3